Madrigal Pharmaceuticals, Inc. (MDGL) Social Stream
MADRIGAL PHARMACEUTICALS INC (MDGL) Price Targets From Analysts
Use the tables below to see what analysts covering MADRIGAL PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 11 | $203 | $145 | $174.5 | $231.38 | -24.58% |
| 2021-12-30 | 10 | $203 | $145 | $173.714 | $231.38 | -24.92% |
| 2022-02-25 | 10 | $203 | $131 | $167.571 | $231.38 | -27.58% |
| 2022-05-11 | 10 | $203 | $129 | $161.5 | $231.38 | -30.2% |
| 2022-05-12 | 10 | $203 | $129 | $156.25 | $231.38 | -32.47% |
| 2022-05-26 | 9 | $203 | $129 | $156.25 | $231.38 | -32.47% |
| 2022-08-04 | 9 | $203 | $75 | $149.25 | $231.38 | -35.5% |
| 2022-09-02 | 8 | $203 | $75 | $149.25 | $231.38 | -35.5% |
| 2022-11-10 | 7 | $203 | $75 | $141.875 | $231.38 | -38.68% |
| 2022-12-07 | 8 | $203 | $75 | $141.875 | $231.38 | -38.68% |
| 2022-12-20 | 10 | $280 | $75 | $151.5 | $231.38 | -34.52% |
| 2022-12-21 | 11 | $375 | $194 | $289.75 | $231.38 | 25.23% |
| 2023-01-05 | 11 | $390 | $194 | $296.25 | $231.38 | 28.04% |
| 2023-02-24 | 11 | $390 | $194 | $303 | $231.38 | 30.95% |
| 2023-02-27 | 11 | $390 | $194 | $305.083 | $231.38 | 31.85% |
| 2023-05-09 | 10 | $390 | $194 | $312.583 | $231.38 | 35.1% |
| 2023-05-15 | 12 | $396 | $194 | $319.833 | $231.38 | 38.23% |
| 2023-05-16 | 12 | $396 | $194 | $324 | $231.38 | 40.03% |
| 2023-08-08 | 12 | $396 | $224 | $326.5 | $231.38 | 41.11% |
| 2023-09-01 | 12 | $396 | $224 | $321.083 | $231.38 | 38.77% |
| 2023-09-13 | 12 | $396 | $224 | $322.333 | $231.38 | 39.31% |
| 2023-09-26 | 13 | $396 | $224 | $322.333 | $231.38 | 39.31% |
| 2023-11-08 | 13 | $396 | $154 | $316.5 | $231.38 | 36.79% |
| 2023-11-13 | 13 | $396 | $154 | $320.666 | $231.38 | 38.59% |
| 2023-11-14 | 13 | $396 | $154 | $320.083 | $231.38 | 38.34% |
| 2023-11-20 | 13 | $383 | $154 | $306.333 | $231.38 | 32.39% |
The Trend in the Analyst Price Target
Over the past 32 months, MDGL's average price target has gone up $144.63.
MDGL reports an average of 48.23% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-05 | 11 | 390 | 194 | 296.250 | 271.71 | 9.03% |
| 2023-02-27 | 12 | 390 | 194 | 309.250 | 271.62 | 13.85% |
| 2023-02-28 | 12 | 390 | 194 | 312.583 | 271.01 | 15.34% |
| 2023-05-09 | 12 | 390 | 194 | 312.583 | 299.65 | 4.32% |
| 2023-08-14 | 12 | 396 | 224 | 321.083 | 173.44 | 85.13% |
MDGL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.31 | 11 | 0 | 2 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
MDGL's average broker recommendation rating improved by 0.76 over the prior 27 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MDGL as an investment opportunity.
- In terms of how MADRIGAL PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is greater than 3097.07% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, MADRIGAL PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 645.21% of them.
- MDGL has a higher number of analysts covering the stock than 2623.7% of stocks in the mid market cap category.
- In terms of how MADRIGAL PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -2253.71% of that group.
In the Pharmaceutical Products industry, MGNX, CYRX, and INSM are the three stocks most similar to MADRIGAL PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is MDGL a Buy, Hold or Sell? See the POWR Ratings now!